APRIL WARD: Open Payments
NPI 1649597345 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 39 payments from 9 companies in 2025. Trend: 2023 $350 · 2024 $702 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 22 | $262 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| ABBVIE INC. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Alkermes, Inc. | 1 | $31 |
Products named: ABILIFY ASIMTUFII, FANAPT, VRAYLAR, CAPLYTA, REXULTI, INGREZZA, Auvelity, INVEGA SUSTENNA.
Industry payments across MS — which companies pay providers there.
